Together, these IMC and transcriptomic analyses demonstrate spatial, morphological, and signaling evidence supporting the presence and functional relevance of hybrid immune-epithelial (CK+CD45+) populations in metastatic prostate cancer. Here, PTPRC is linked to metastatic prostate carcinoma.